Vanta Bioscience Stock Price Analysis and Quick Research Report. Is Vanta Bioscience an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Vanta Bioscience. 

• PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Vanta Bioscience has a PE ratio of -6.288433773595 which is low and comparatively undervalued.

• Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Vanta Bioscience has ROA of 0.0977% which is a bad sign for future performance. (Higher values are always desirable.)

• Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Vanta Bioscience has a Current ratio of 0.8468.

• Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Vanta Bioscience has a ROE of 0.2583%. (Higher is better)

• Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Vanta Bioscience has a Debt to Equity ratio of 1.2823 which means that the company has low proportion of debt in its capital.

• Sales growth: Vanta Bioscience has reported revenue growth of 65.4988% which is fair in relation to its growth and performance. 

• Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Vanta Bioscience for the current financial year is 42.6767283133382%.

• Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Vanta Bioscience is Rs 0 and the yield is 0%.

• Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Vanta Bioscience is Rs -3.7402. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Vanta Bioscience in Ticker for free. Also, one can get the intrinsic value of Vanta Bioscience by using Valuation Calculators, which are available with a Finology ONE subscription. 

Vanta Bioscience FAQs

Q1. What is Vanta Bioscience share price today?
Ans: The current share price of Vanta Bioscience is Rs 23.52.

Q2. What is the market capitalisation of Vanta Bioscience?
Ans: Vanta Bioscience has a market capitalisation of Rs 16.727424 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Vanta Bioscience?
Ans: The PE ratio of Vanta Bioscience is -6.288433773595 and the P/B ratio of Vanta Bioscience is 0.703046534984935, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Vanta Bioscience share?
Ans: The 52-week high share price of Vanta Bioscience is Rs 56, and the 52-week low share price of Vanta Bioscience is Rs 19.08.

Q5. Does Vanta Bioscience pay dividends?
Ans: Currently, Vanta Bioscience does not pay dividends. Dividend yield of Vanta Bioscience is around 0%.

Q6. What are the face value and book value of Vanta Bioscience shares?
Ans: The face value of Vanta Bioscience shares is Rs 10, while the book value per share of Vanta Bioscience is around Rs 33.4544. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Vanta Bioscience?
Ans: Vanta Bioscience has a total debt of Rs 25.380159 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Vanta Bioscience?
Ans: The ROE of Vanta Bioscience is 0.2583% and ROCE of Vanta Bioscience is 5.4348%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Vanta Bioscience a good buy for the long term?
Ans: The Vanta Bioscience long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Vanta Bioscience undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Vanta Bioscience appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Vanta Bioscience’s financials?
Ans: You can review Vanta Bioscience’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.